Molecular Targeted Radionuclide Therapy for Prostate Cancer

Main Article Content

Saima Muzahir, MD
Erin E. Grady, MD
Scott J. Lee, MD


According to the American Cancer Society, prostate cancer affects 1 in 8 men. This chapter reviews the molecular targeted radionuclide therapy for prostate cancer, including pretherapy imaging and evaluation, considerations during the course of therapy, and follow-up. Dosimetry and alpha-particle therapies are also discussed.


Download data is not yet available.


Metrics Loading ...

Article Details

Chapter 10